Cannabidiol as a new type of an antipsychotic: results from a placebo-controlled clinical trial

Category Primary study
Conference67th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry
Year 2012

This article is included in 2 Systematic reviews Systematic reviews (2 references) 1 Broad synthesis Broad syntheses (1 reference)

This article is part of the following publication threads:
This article is part of the following matrixes of evidence:
Loading references information
Biol Psychiatry. 2012;78(8)(suppl 1):63S
Epistemonikos ID: 639793cc1f97f2485a5aec929bad255d79da1f25
First added on: Jul 05, 2015